Insilico Medicine vs Recursion
Which Healthcare AI tool is better in 2026?
Insilico Medicine
Accelerating drug discovery and development through generative AI and advanced bioinformatics platforms.
Recursion
Pioneering AI-driven solutions in drug discovery to radically improve lives.
Side-by-side
Insilico Medicine is the more established option (raised $510M); pricing is comparable on both sides.
| Metric | Insilico Medicine | Recursion |
|---|---|---|
| Taglinei | Accelerating drug discovery and development through generative AI and advanced bioinformatics platforms. | Pioneering AI-driven solutions in drug discovery to radically improve lives. |
| Foundedi | — | 2013🏆 |
| HQi | US | Salt Lake City, US |
| Employeesi | 201-500 | 501-1000🏆 |
| Neuron scorei | 72 | 76🏆 |
| Total fundingi | $510M🏆 | $500M |
| Latest roundi | Series E · Mar 2025 | IPO · Apr 2021 |
| Valuationi | — | $2B🏆 |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Enterprise · Contact sales | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Insilico Medicine and Recursion.
| Capability | Insilico Medicine | Recursion |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Insilico Medicine
- Has raised more capital ($510M vs $500M)
🔵 Strengths of Recursion
- Higher Neuron score (76 vs 72)
- Newer company (2013)
Which should you choose?
Choose Recursion if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Insilico Medicine if you want the most established option — it has raised $510M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Insilico Medicine vs Recursion — which is better?
It depends on your priority. Insilico Medicine has raised more capital and is the more established option; Recursion has broader feature depth. See the side-by-side table above.
Is Insilico Medicine cheaper than Recursion?
No — Recursion's cheapest paid plan is Enterprise · Contact sales, while Insilico Medicine's is Enterprise · Contact sales.
Do Insilico Medicine and Recursion offer free plans?
Insilico Medicine: Paid only. Recursion: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.